← Back to headlines
Alnylam and Inceptive Partner on AI for RNAi Therapy Development
Alnylam Pharmaceuticals announced a collaboration with Inceptive to leverage artificial intelligence for the development of RNA interference (RNAi) therapies.
3 Jun, 21:49 — 3 Jun, 21:49
Sources
Showing 1 of 1 sources
